Do glycaemic treatment targets affect the perinatal mental health status of women with gestational diabetes? – Data from the TARGET Trial

Table 2 Mental health measures at trial entry (baseline)

Outcome	Tight glycaemic targets (n = 225)	Less-tight glycaemic targets (n = 189)	p-value
Poor mental health composite^a	60/214 (28.0)	45/182 (24.7)	0.46
Anxiety (STAI > 15)	44/219 (20.1)	27/189 (14.3)	0.12
STAI score	11.0 ± 3.4	11.0 ± 3.6	0.92
Depression (EPDS > 12)	34/220 (15.5)	32/185 (17.3)	0.62
EPDS score	7.6 ± 4.9	7.6 ± 4.6	0.98
Poor mental HRQoL (MCS < 40)	36/220 (16.4)	32/184 (17.4)	0.80
SF-36 scores
General health	69.9 ± 18.8	70.6 ± 16.7	0.68
Mental health	68.1 ± 11.8	68.1 ± 12.4	0.94
Physical functioning	60.9 ± 22.8	64.5 ± 20.9	0.09
Social functioning	73.8 ± 23.4	76.3 ± 23.7	0.29
Role physical	49.1 ± 39.8	53.8 ± 40.1	0.23
Role emotional	77.7 ± 36.0	82.5 ± 32.7	0.16
Bodily pain	63.2 ± 22.6	64.5 ± 21.4	0.53
Vitality	54.5 ± 14.4	51.5 ± 14.7	0.04
PCS	41.5 ± 9.5	42.8 ± 8.2	0.14
MCS	48.5 ± 7.7	48.5 ± 8.4	0.99

^aAny of anxiety (STAI > 15), vulnerability to depression (EPDS > 12) or poor mental health-related quality of life (SF-36 MCS < 40)
All variables presented as number (percentage) or mean ± standard deviation unless otherwise indicated
EPDS Edinburgh Postnatal Depression Scale, HRQoL health-related quality of life, MCS Mental Component Summary, PCS Physical Component Summary, STAI Spielberger State-Trait Anxiety Inventory, SD standard deviation, SF-36 36-Item Short-Form General Health Survey

ISSN: 1471-2393